Gestational Diabetes Screening at 21 Weeks for Travel Considerations

Standard Timing for GDM Screening

The U.S. Preventive Services Task Force (USPSTF) recommends screening for gestational diabetes mellitus (GDM) after 24 weeks of gestation 1, 2
Standard practice involves performing the screening between 24-28 weeks of gestation, when glucose tolerance typically deteriorates during pregnancy 3, 4
This timing is based on the physiological changes in glucose metabolism that occur during the second half of pregnancy 5

The USPSTF acknowledges that "screening for GDM may occur earlier than 24 weeks of gestation in high-risk women, but there is little evidence about the benefits and harms of screening before 24 weeks of gestation" 1, 2
Clinicians should use their clinical judgment to determine appropriate screening for individual patients given their specific health needs 1, 6

Obesity is a higher risk factor for GDM 1, 2
Increased maternal age is a higher risk factor for GDM 1, 2
History of previous GDM is a higher risk factor for GDM 1, 2
Family history of diabetes is a higher risk factor for GDM 1, 2
Belonging to high-risk ethnic groups (Hispanic, Native American, South or East Asian, African American, or Pacific Island descent) is a higher risk factor for GDM 1, 2

For a patient at 21 weeks gestation planning international travel, performing the GDM screening is reasonable and preferable to delaying or missing screening 2
Use the standard screening methods: Two-step approach: 50g glucose challenge test (GCT) in non-fasting state, followed by 100g OGTT if screening threshold is met 1, 2
Or one-step approach: 75g OGTT with evaluation of fasting, 1-hour, and 2-hour glucose levels 5, 7

If GDM is diagnosed at 21 weeks, initiate standard GDM management including dietary changes, physical activity, glucose monitoring, and medication if needed 1, 2
If screening is negative at 21 weeks, provide the patient with information about symptoms of hyperglycemia to monitor while traveling 5
Regardless of the screening result, all women with GDM should be rescreened 4-12 weeks postpartum with a 75g OGTT to assess for persistent glucose abnormalities 8